CTLA4 and neoplasm: Meanwhile, the authors found that TNF blockade could further enhance the infiltration of tumor-specific CD8+ T cells into the tumor microenvironment and draining lymph nodes caused by anti–PD-1 and anti–CTLA-4 monoclonal antibody combination therapy (89).